Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: An intergroup trial

Journal of Clinical Oncology

Volumn 15, Issue 9, 1997, Pages 3093-3099

  Loehrer Sr , Patrick J ^a   Chen, Michael ^a   Kim, KyungMann ^a   Aisner, Seena C ^a   Einhorn, Lawrence H ^a   Livingston, Robert ^a   Johnson, David ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; HISTOLOGY; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNE RESPONSE; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; SURVIVAL RATE; THYMOMA; TREATMENT FAILURE;

EID: 0342871976     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.9.3093     Document Type: Article

References (18)

1. Batata MA, Martini N, Huvos AG, et al: Thymomas: Clinicopathologic features, therapy, and prognosis. Cancer 34:389-396, 1974
2. Legg MA, Brady WJ: Pathology and clinical behaviour of thymomas: A survey of 51 cases. Cancer 18:1131-1144, 1965
3. Maggi G, Giaccone G, Donadio M, et al: Thymomas. A review of 169 cases, with particular reference to results of surgical treatment. Cancer 58:765-776, 1986
4. Loehrer PJ, Kim KM, Aisner SC, et al: Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: Final results of an intergroup trial. J Clin Oncol 12:1164-1168, 1994
5. Boston B: Chemotherapy of invasive thymoma. Cancer 38:49-52, 1976
6. Campbell MG, Pollard R, Al-Sarraf M: A complete response in metastatic malignant thymoma to cisplatinum, doxorubicin, and cyclophosphamide. Cancer 98:1315-1317, 1981
7. Loehrer PJ, Perez CA, Roth LM, et al: Chemotherapy for advanced thymoma: Preliminary results of an intergroup study. Ann Int Med 113:520-524, 1990
8. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-81, 1958
9. Masaoka A, Monden Y, Nakahara K, et al: Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485-2492, 1981
10. Monden Y, Nakahara K, Iioka S, et al: Recurrence of thymoma: Clinicopathologic features, therapy and prognosis. Ann Thorac Surg 39:165-169, 1985
11. Haniuda M, Morimoto M, Nishimura H, et al: Adjuvant radiotherapy after complete resection of thymoma. Ann Thorac Sur 54:311-315, 1992
12. Pollack A, Komaki R, Cox JD, et al: Thymoma: Treatment and prognosis. Int J Radiat Oncol Biol Phys 23:1037-43, 1992
13. Curran WJ, Kornstein MJ, Brooks JJ, et al: Invasive thymoma: The role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 6:1722-1717, 1988
14. Arriagada R, Bretel JJ, Caillaud JM, et al: Invasive carcinoma of the thymus. A multicenter retrospective review of 56 cases. Eur J Cancer Clin Oncol 20:69-74, 1984
15. Mornex F, Resbeut M, Richard P, et al: Radiotherapy and chemotherapy for invasive thymoma: A multicentric retrospective review of 90 cases. Int J Radiat Oncol Biol Phy 32:651-659, 1995
16. Koh WJ, Loehrer PJ, Thomas CR: Thymoma: Radiation and chemotherapy, in Wood DE, Thomas CR (eds): Mediastinal Tumors: Update 1995. New York, Springer-Verlag, 1995, pp 19-26
17. Macchiarini P, Chella A, Ducci F, et al: Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 68:706-713, 1991
18. Fornasiero A, Daniele O, Ghiotto C, et al: Chemotherapy for invasive thymoma: A 13-year experience. Cancer 68:30-33, 1991